Jasleen Gill

Ms. Jasleen Gill

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2025 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
LLLev Litichevskiy
Lev Litichevskiy
MCMaya Considine
Maya Considine
JGJasleen Gill
Jasleen Gill
VSVasuprada Shandar
Vasuprada Shandar
TCTimothy O. Cox
Timothy O. Cox
CTChristoph A. Thaiss
Christoph A. Thaiss

1 January 2026 in Cells
Verified
Journal Article
Open access
PDF file
SMStephanie Michelle Mueller
Stephanie Michelle Mueller
NMNalani Miller
Nalani Miller
JGJasleen Gill
Jasleen Gill
LYLaYow Christine Yu
LaYow Christine Yu
MPMichael Drake Pike
Michael Drake Pike
DODennis P. Orgill
Dennis P. Orgill
(1) Background: Wound healing is a highly coordinated process encompassing hemostasis, inflammation, angiogenesis, keratinocyte migration, collagen deposition, and extracellular matrix remodeling. Successful repair also requires adequate nutrient and oxygen delivery through a well-developed vascular supply. Disruption of these processes can occur through aberrations in diverse biological pathways, including extracellular matrix organization, cellular adhesions, angiogenesis, and immune regulation. (2) Methods: We reviewed mechanisms of impaired tissue repair in monogenic disorders by focusing on three categories—connective tissue, hematological/immunological, and aging-related disorders—to illustrate how single-gene defects disrupt inflammation, cellular proliferation, and matrix remodeling. Additionally, we reviewed various polygenic disorders—chronic kidney disease, diabetes mellitus, hypertension, and obesity—to contrast complex multifactorial pathologies with single-gene defects. (3) Results: This review establishes that genetic impediments, despite their distinct etiologies, monogenic and polygenic disorders share critical downstream failures in the wound healing cascade. While monogenic diseases illustrate direct causal links between specific protein deficits and repair failure, polygenic diseases demonstrate how multifactorial stressors overwhelm the body’s regenerative capacity. (4) Conclusions: This review synthesizes current evidence on both monogenic diseases and polygenic contributions to impaired wound healing. These findings highlight that genetic susceptibility is a decisive factor in the ability to restore tissue homeostasis. This underscores the profound impact of genetic background on the efficacy of hemostasis, inflammation, and remodeling.

26 July 2024 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
JGJasleen Gill
Jasleen Gill

29 November 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
LLLev Litichevskiy
Lev Litichevskiy
MCMaya Considine
Maya Considine
JGJasleen Gill
Jasleen Gill
VSVasuprada Shandar
Vasuprada Shandar
TCTimothy O. Cox
Timothy O. Cox
CTChristoph A. Thaiss
Christoph A. Thaiss
Summary: The intestinal microbiome changes with age, but the causes and consequences of microbiome aging remain unclear. Furthermore, the gut microbiome has been proposed to mediate the benefit of lifespan- extending interventions such as dietary restriction, but this hypothesis warrants further exploration. Here, by analyzing 2997 metagenomes collected longitudinally from 913 deeply phenotyped, genetically diverse mice, we provide new insights into the interplay between the microbiome, aging, dietary restriction, host genetics, and a wide range of health parameters. First, we find that microbiome uniqueness increases with age across datasets and species. Moreover, age-associated changes are better explained by cumulative exposure to stochastic events (neutral theory) than by the influence of an aging host (selection theory). Second, we unexpectedly find that the majority of microbiome features are significantly heritable and that the amount of variation explained by host genetics is as large as that of aging and dietary restriction. Third, we find that the intensity of dietary restriction parallels the extent of microbiome changes and that dietary restriction does not rejuvenate the microbiome. Lastly, we find that the microbiome is significantly associated with multiple health parameters — including body composition, immune parameters, and frailty — but not with lifespan. In summary, this large and multifaceted study sheds light on the factors influencing the microbiome and aspects of host physiology modulated by the microbiome.

11 March 2026 in Journal of the American Chemical Society
Verified
Journal Article
Open access
CLChristian E. Loo
Christian E. Loo
JPJared B. Parker
Jared B. Parker
ABAleksia Barka
Aleksia Barka
RZRuiyao Zhu
Ruiyao Zhu
MSMatthew R. Schnell
Matthew R. Schnell
RKRahul M. Kohli
Rahul M. Kohli
The interplay of genetic and epigenetic information shapes cell identity, development, and disease. However, standard methods for profiling DNA modifications (e.g., bisulfite sequencing) rely on selective C-to-T conversions, hindering the simultaneous examination of both genetic and epigenetic information. Here, we introduce Integrated Sequencing, which provides high-fidelity mapping of DNA modifications while preserving the native four-base genetic code in single DNA molecules. Integrated-Seq leverages the synthesis of a tethered copy strand with unnatural cytosine analogs that resist enzymatic conversion, combined with a novel DNA deaminase-helicase fusion that drives selective C-to-T conversion of natural cytosines in the original template strand. We demonstrate that Integrated-Seq is compatible with customizable enzymatic readouts to parse 5-methylcytosine and 5-hydroxymethylcytosine, and that preservation of the original four-base genetic code markedly improved enrichment, facilitating analysis of targeted genomic regions. Integrated-Seq thus provides a platform for simultaneous genetic and epigenetic analyses, paving the way for deep insights into fundamental biology and next-generation diagnostics.

13 November 2026 in medRxiv
Verified
Preprint
Open access
ZSZili Shen
Zili Shen
ARAnu Ramachandran
Anu Ramachandran
EHElaine Hsiang
Elaine Hsiang
JGJasleen Gill
Jasleen Gill
RMRyan Miller
Ryan Miller
NSNicholas R Stark
Nicholas R Stark
Agentic healthcare platforms that combine large language models with physician oversight are growing quickly, but little is known about who uses them. We characterized 3,223 enrollees of Lotus AI, a free, physician-supervised agentic platform, who completed onboarding, messaged the agent, and had a linked health record between February and July 2026, and compared them with national benchmarks. Median age was 51 years and 62% were male. Chronic condition prevalence exceeded 2024 National Health Interview Survey estimates in every age band by 4 to 7 percentage points; 18% had a functional or symptom-defined disorder; among the 30% with four or more ambulatory visits in the prior year, care was spread across nearly five providers, with 44% meeting a threshold for high fragmentation. Users with functional disorders generated 1.8 times as many physician escalations and 2.6 times as many laboratory orders as other users, but no more prescriptions. This profile differs from the younger, predominantly female populations reported for direct-to-consumer telemedicine. It moves chronic disease management, functional disorder pathways, and care coordination from aspirations to design requirements, and we argue that deployed AI care platforms should characterize their populations against national benchmarks early.